Aldabra 4

Where it stands

Searching · next dated event 23 January 2028

Outside date — not a date on which you can claim cash.

Merging with

No target announced — still searching.

Industry

no filing we hold states a sector this SPAC restricted its search to

Deal value

not stated in the filings we hold

Price vs cash floor

$9.98 vs $10.00

$0.02 below the last filed cash held for you; 1.0% below cash against our estimated ~$10.08

Cash left in trust

$303.9M

IPO

22 January 2026

$300M raised · 100.0% of each $10 unit into trust

Headquarters

3725 LEAFY WAY, MIAMI, FL, 33133

registered in the Cayman Islands

Lead underwriter

Cantor Fitzgerald & Co.

Key officers

NEAL YANOFSKY (Chief Executive Officer) · SCHIFRIN STEPHEN SIMON (See Remarks) · Schecter Carl Benjamin (Director)

Listed securities

ALOV common · ALOVW warrant $0.44 · ALOV common $10.01 · ALOVU unit $10.28

1. No dated redemption election is on file for this name. That is an absence in the record, not proof that the right has gone — but it does mean this page cannot tell you a day to act by.
2. Cash held in trust is $10.00 per share as last filed. That is the figure a redemption pays out at, plus whatever interest the trust earns between the filing and the window.
3. The charter runs to 23 January 2028. If no deal closes by then the trust is returned to holders, which is a floor of a different kind — it pays out, but you do not choose when.

1. 22 January 2026IPOpassed

   $300M raised into trust

2. 23 January 2028Outside date0001104659-26-096074

• 10-Q13 August 20260001104659-26-096074

  Management explicitly discloses that the entity’s current liquidity condition 'raises substantial doubt about the Company’s ability to continue as a going concern.' Unrestricted operating cash sits at $891,230 while contractual obligations include a $30,000 monthly administrative support fee payable to the sponsor. Because the SPAC has generated zero operating revenue and continues to incur pre-acquisition search costs, investors should anticipate imminent requests for additional non-interest-bearing working capital advances from insiders to preserve the trust corpus through the remainder of the 24-month completion window. Absent fresh funding or a binding target agreement, forced liquidation risk increases as external cash reserves draw down against fixed overhead.

• 10-Q15 May 20260001104659-26-062446

  Investors tracking redemption floors can update their expected return calculations to the newly accreted $10.06 per share based on accrued interest. The unchanged January 2028 deadline and explicit confirmation of zero target discussions indicate the SPAC is functioning in its standard pre-deal accumulation phase, ruling out imminent extension votes or near-term merger announcements. Routine sponsor payments confirm standard capital preservation mechanics are intact without adverse deviations.

• 10-K30 March 20260001104659-26-036353

  It permanently locks in the SPAC's capital mechanics, confirming the final trust balance of $300,150,000, the total public float, and the hard liquidation deadline of January 23, 2028, eliminating pre-offering uncertainties regarding cap table and redemption triggers. The filing also codifies the sponsor's economic positioning—noting the purchase of 7,503,750 Class B founder shares for $25,000 to secure a 20% equity stake—and outlines the framework for potential working capital loans (capped at $1,500,000, convertible into warrants at $1.00 each), as detailed in the related party transactions section. Additionally, it introduces governance safeguards adopted by the board of directors, including a Nasdaq-compliant executive compensation clawback policy for accounting restatements and explicit insider trading blackout windows and pre-clearance protocols for officers and directors.

• 8-K29 January 20260001104659-26-008075

  This filing establishes the baseline trust value of $300,150,000 ($10.00 per share) required for future redemptions and fixes the mandatory liquidation deadline at January 23, 2028. Investors tracking deal progress will note the Company's stated policy that targets must hold an aggregate fair market value of at least 80% of the trust account excluding deferred discounts and taxes. The resolution of the over-allotment removes forfeiture risk for the 7,503,750 founder shares initially purchased by the sponsor for $25,000. Ongoing operational costs are quantified by the administrative support agreement requiring payments of up to $10,000 per month to the sponsor. The working capital loan facility allows up to $1,500,000 convertible into warrants at $1.00 per warrant, and registration rights cover up to 13,370,416 shares and 5,866,666 warrants. The filing confirms management's conclusion that substantial doubt regarding going concern has been alleviated following the trust deposit and the retention of $1,813,190 in working capital cash.

• 8-K27 January 20260001104659-26-007008

  This filing definitively starts the 24-month survival window anchored to the January 23, 2026 closing date, locking the redemption floor at the documented $10.00 per Unit deposit while preserving the $12,789,000 deferred compensation for payout exclusively upon a successful merger or pro-rata distribution to shareholders upon liquidation. The explicit disclosures of zero target identification and zero active negotiations confirm the vehicle is in the pure search phase, meaning all near-term value accrual or erosion depends entirely on sponsor execution speed, the $30,000 monthly overhead burn rate, and the structural safeguards (like warrant holder waivers and insider lock-ups) outlined in the contractual exhibits. With the board expanded to five members and regulatory compliance confirmed, the mechanical parameters for redemptions, extensions, and eventual exits are now fully operational for tracked investors.

• 424B422 January 20260001104659-26-005826

  These provisions fix the exit floor, dilution vectors, and sponsor alignment profile ahead of any deal pipeline development. The prospectus outlines a strategy targeting enterprise values between $500 million and $2 billion, with investment themes centered on demographic shifts, under-managed intellectual property, competitive restructuring, and technology disruption.

• 10-Q13 August 20260001104659-26-096074

  What changed: Form 10-Q quarterly report for the period ended June 30, 2026. No modifications to the redemption calendar, warrant mechanics, or the January 23, 2028 Completion Period deadline. Following the January 23, 2026 IPO, the Trust Account holds $303,899,962, establishing a stated redemption value of $10.12 per share. The sponsor’s $250,000 promissory note was settled at IPO closing, and no working capital loans are currently outstanding. General and administrative expenses totaled $862,073 for the six months ended June 30, 2026, while interest income from marketable securities reached $3,749,962, producing reported net income of $2,887,889. Why it matters: Management explicitly discloses that the entity’s current liquidity condition 'raises substantial doubt about the Company’s ability to continue as a going concern.' Unrestricted operating cash sits at $891,230 while contractual obligations include a $30,000 monthly administrative support fee payable to the sponsor. Because the SPAC has generated zero operating revenue and continues to incur pre-acquisition search costs, investors should anticipate imminent requests for additional non-interest-bearing working capital advances from insiders to preserve the trust corpus through the remainder of the 24-month completion window. Absent fresh funding or a binding target agreement, forced liquidation risk increases as external cash reserves draw down against fixed overhead.

  What changed vs 2026-05-15trust $302.1M → $303.9M +1%going concern APPEAREDsponsor loan $300K → $250K
  trust account, going-concern doubt, sponsor loans outstanding +23 moved · 2 with no prior record of ours

  Trust account

  $302.1M→$303.9M

  SpacBrain reads this as $1,849,247 was added to the trust between the two filings.

  The clause …“​ 101,523 ​ ​ — Total current assets ​ 992,753 ​ 23,583 Marketable securities held in Trust Account ​ ​ 303,899,962 ​ ​ — Deferred offering costs ​ — ​ 261,481 TOTAL ASSETS ​ $ 304,892,715 ​ $ 285,064 ​ ​ ​ ​ ​ ​ ​ LIABILITIES,”…

  Going-concern doubt

  not stated→stated

  SpacBrain reads this as the substantial-doubt sentence is in this filing and not in the previous one.

  The clause …“of liquidating. Management has determined that the liquidity condition raises substantial doubt about the Company’s ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities”…

  Sponsor loans outstanding

  $300K→$250K

  SpacBrain reads this as $50,000 of sponsor debt has come off.

  The clause …“of its securities. Prior to the Initial Public Offering, the Company had borrowed $250,000 under the Promissory Note. On January 23, 2026, the full balance was repaid in connection with the close of the Initial Public Offering.”…

  Combination deadline

  2028-01-23 · unchanged

  The clause …“then held in the Trust Account in connection therewith. The Company will have until January 23, 2028, 24 months from the closing of the Initial Public Offering, to complete a Business Combination (the “Completion Period”). However,”…

  Redeemable shares

  30.0M · unchanged

  The clause …“issued or outstanding as of June 30, 2026 and December 31, 2025 (excluding 30,015,000 shares subject to possible redemption) ​ — ​ — Class B ordinary shares, $ 0.0001 par value, 20,000,000 shares authorized; 7,503,750 shares issued”…

  Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.

• 10-Q15 May 20260001104659-26-062446

  What changed: SEC Form 10-Q Quarterly Report for Aldabra 4 Liquidity Opportunity Vehicle, Inc. (ALOV) covering the fiscal quarter ended March 31, 2026. According to the filing, the Trust Account balance grew to $302,050,715, establishing a per-share redemption value of $10.06. The mandatory completion deadline remains fixed at January 23, 2028, with no shareholder vote for an extension requested or approved during this period. Deal progress remains in the search phase; the company confirms it has not selected a target nor initiated substantive discussions. Regarding sponsor conduct, the filing notes the full repayment of a non-interest-bearing promissory note and the accrual of $30,000 monthly administrative support fees to the Sponsor, consistent with standard SPAC operations. Why it matters: Investors tracking redemption floors can update their expected return calculations to the newly accreted $10.06 per share based on accrued interest. The unchanged January 2028 deadline and explicit confirmation of zero target discussions indicate the SPAC is functioning in its standard pre-deal accumulation phase, ruling out imminent extension votes or near-term merger announcements. Routine sponsor payments confirm standard capital preservation mechanics are intact without adverse deviations.

• SCHEDULE 13G15 May 20260001104659-26-062630

  What changed: A routine compliance exhibit (Exhibit 99.1) functioning as a Joint Filing Agreement attached to a Schedule 13G, executed on May 15, 2026, to authorize Aldabra 4 LOV Sponsor Partnership, LLC and its Manager, Nathan Leight, to jointly submit beneficial ownership reports under Rule 13d-1(k) concerning the Class A ordinary shares, $0.0001 par value, of Aldabra 4 Liquidity Opportunity Vehicle, Inc. The filing establishes an administrative reporting conduit between the sponsor entity and its designated manager, stipulating that each party independently guarantees the accuracy and completeness of their own submitted data while disclaiming liability for the other’s disclosures. It introduces no modifications to redemption thresholds, trust account distributions, merger candidate selection, or extension voting schedules. All mechanical parameters remain static relative to prior disclosures. Why it matters: For shareholders monitoring liquidity mechanics, sponsorship behavior, or combination execution, this submission reflects standard securities law housekeeping rather than corporate action. The shared filing designation reduces duplicative administrative burdens but carries zero implications for unit redemption pricing, trust yield accumulation, or SPAC operational timelines. The document contains no commentary on market positioning, customer pipelines, revenue forecasts, technological IP, strategic alliances, pending litigation, or executive compensation changes. Consequently, it does not advance or impede the development calendar, and investors should await subsequent transactional or amendment filings for material developments affecting the trust balance or business combination deadline.

• SCHEDULE 13G13 May 20260000919574-26-002908

  What changed: Schedule 13G joint acquisition statement exhibit confirming coordinated beneficial ownership reporting. The text is a procedural acknowledgment establishing a joint-filing arrangement among Adage Capital Management, L.P., Robert Atchinson, and Phillip Gross. Each signer accepts independent legal responsibility for the completeness and accuracy of their respective portions of the Schedule 13G, while agreeing that all subsequent amendments will be filed jointly without supplemental exhibits. No share quantities, ownership percentages, acquisition dates, or price ranges are disclosed in this attachment. Why it matters: For a SPAC actively in the SEARCHING phase, tracking institutional co-positioning helps investors anticipate potential advisory alliances, PIPE commitments, or board influence ahead of a merger announcement. This exhibit confirms Adage Capital’s coordinated stance in ALOV but provides no substantive update on trust accounting, redemption mechanics, extension votes, or target development. Because the excerpt contains only administrative boilerplate dated May 13, 2026, it does not shift existing liquidity windows or sponsor obligations. Investors needing precise holding sizes, threshold crossings, or historical accumulation data must examine the primary Schedule 13G body to which this exhibit is attached.

• 10-K30 March 20260001104659-26-036353

  What changed: Form 10-K annual report for a blank check company in the search phase. The filing discloses that subsequent to the December 31, 2025 reporting period, the company consummated its initial public offering on January 23, 2026. According to management's disclosure, 30,015,000 units were sold at $10.00 per unit, generating $300,150,000 in gross proceeds, all of which were deposited into the Trust Account. The filing establishes the mandatory business combination deadline as 24 months from IPO closing, specifically January 23, 2028. In the event of a failed combination, public shareholders may redeem their shares for a pro rata portion of the Trust Account balance, minus taxes payable and up to $100,000 of interest allocated for dissolution expenses, as stated in the risk factors and organizational description. The company also notes that the underwriters have agreed to waive their deferred underwriting commission of $12,789,000 if a business combination is not completed. Historically, from inception through December 31, 2025, the company reported a net loss of $78,082, held $23,583 in operating cash, and carried a $200,000 promissory note from the sponsor that was fully settled at the IPO closing. Why it matters: It permanently locks in the SPAC's capital mechanics, confirming the final trust balance of $300,150,000, the total public float, and the hard liquidation deadline of January 23, 2028, eliminating pre-offering uncertainties regarding cap table and redemption triggers. The filing also codifies the sponsor's economic positioning—noting the purchase of 7,503,750 Class B founder shares for $25,000 to secure a 20% equity stake—and outlines the framework for potential working capital loans (capped at $1,500,000, convertible into warrants at $1.00 each), as detailed in the related party transactions section. Additionally, it introduces governance safeguards adopted by the board of directors, including a Nasdaq-compliant executive compensation clawback policy for accounting restatements and explicit insider trading blackout windows and pre-clearance protocols for officers and directors.

At-risk capital: $7.3M — 4,866,666 private placement warrants, bought at the IPO and worthless if the company liquidates. This is what the sponsor itself loses if no deal closes. per the prospectus (424B4 0001104659-26-005826)